LAPAROSCOPIC LYMPH NODE RESECTION OF POST-CHEMOTHERAPY (POST-CHT) RESIDUAL RETROPERITONEAL (RP) TUMOR MASSES IN PATIENTS WITH NON-SEMINOMATOUS TESTICULAR GERM-CELL TUMORS (NSTGCT)

被引：0
|
作者：
Sullivan, I. G. [1 ]
Anguera, G. [1 ]
Arqueros, C. [1 ]
Condori, D. [1 ]
Palou, J. [2 ]
Pena, J. A. [2 ]
Villavicencio, H. [2 ]
Maroto, P. [1 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[2] Fundacio Puigvert, Dept Urol, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：292 / 292
页数：1
相关论文
共 50 条
  • [21] SIMULTANEOUS VERSUS SEQUENTIAL RETROPERITONEAL AND THORACIC RESECTION OF POST CHEMOTHERAPY RESIDUAL MASSES IN PATIENTS WITH METASTATIC NON-SEMINOMATOUS GERM CELL TUMORS OF THE TESTIS
    Nason, Gregory
    Donahoe, Laura
    Aditya, Ishan
    De Perrot, Marc
    Anson-Cartwright, Lynn
    Jewett, Michael
    Hansen, Aaron
    Bedard, Philippe
    Warde, Padraig
    Chung, Peter
    Sweet, Joan
    O'Malley, Martin
    Hamilton, Robert
    JOURNAL OF UROLOGY, 2019, 201 (04): : E1068 - E1068
  • [22] SUCCESSFUL RESECTION OF POST-CHEMOTHERAPY METASTASES FROM NON-SEMINOMATOUS GERM CELL TESTICULAR CANCER
    Morelli, Franco
    Capotorto, Anna Maria
    Lombardi, Lucia
    Setola, Pasquale
    Sebastio, Nicola
    Cisternino, Antonio
    Maiello, Evaristo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1424 - 1425
  • [23] Robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumour in a centralised post-chemotherapy surgical practice
    Thomas, B.
    Lee, E.
    Coret, M.
    BJU INTERNATIONAL, 2018, 121 : 27 - 28
  • [24] Indication of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) in the treatment of non-seminomatous germ-cell tumors of the testis (NSGCTT):: The case of minimal initial and residual disease.
    Tavernier, E
    Fléchon, A
    Méeus, P
    Rivoire, M
    Droz, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 406S - 406S
  • [25] Post-chemotherapy retroperitoneal lymph node dissection can not be safely omitted in patients with metastatic non-seminomatous germ cell testis cancer
    Nguyen, Carvell T.
    Subramanian, Vairavan S.
    Stephenson, Andrew J.
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 176 - 176
  • [26] Post-chemotherapy residual masses <15 mm in patients with metastatic non seminomatous germ cell tumors: is resection required?
    Albouy, B.
    Massard, C.
    Bessede, T.
    Loriot, Y.
    Rouge, T. De la Motte
    Gross-Goupil, M.
    Bossi, A.
    Escudier, B.
    Fizazi, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 442 - 442
  • [27] Management of the post-chemotherapy residual mass in patients with advanced stage non-seminomatous germ cell tumors (NSGCT)
    Kuczyk, M
    Machtens, S
    Stief, C
    Jonas, U
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (06) : 852 - 855
  • [28] Study of the conformity of post-chemotherapy retroperitoneal lymph-node dissection (RPLND) to standard recommendations in patients with testicular (T) and primary retroperitoneal (PR) non-seminomatous germ-cell tumor (NSGCT): Impact on outcome.
    Flechon, A
    Tavernier, E
    Meeus, P
    Rivoire, M
    Droz, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 402S - 402S
  • [29] NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS - MORPHOLOGY OF RETROPERITONEAL LYMPH-NODE METASTASES AFTER CHEMOTHERAPY
    SUURMEIJER, AJH
    OOSTERHUIS, JW
    SLEIJFER, DT
    KOOPS, HS
    FLEUREN, GJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1984, 20 (06): : 727 - 734
  • [30] Retroperitoneal laparoscopic lymph node dissection for staging non-seminomatous germ cell tumors before and after chemotherapy
    Rassweiler, JJ
    Henkel, TO
    Stock, C
    Seemann, O
    Frede, T
    Alken, P
    LYMPHOLOGY, 1996, 29 (01) : 36 - 44
12345